AUTIFONY ALPHA LIMITED - Profile & Financials

Accounts Submitted 16 Jun 2025

Confirmation Statement Submitted 4 Apr 2025

Net assets £371.83K £97.00 2024 year on year

Total assets £0.00 £412.03K 2024 year on year

Total Liabilities £27.43K £12.67K 2024 year on year

Charges None No charges registered

AI Analysis

Analyze director networks, ownership patterns, and company connections

CompanyTrack AI can make mistakes. Check important info.

Contact & Details

Contact

Update Details

Registered Address

Stevenage Bioscience Catalyst Gunnels Wood Road Stevenage Hertfordshire SG1 2FX

Credit Report

Discover AUTIFONY ALPHA LIMITED's Credit Score, limit, and payment likelihood.

Mutual Companies

See All Mutual Companies

Financials

Period 1 Jan → 31 Dec 2024

Type Total Exemption Full

Next accounts 31 December 2025

Due by 30 September 2026 9 months

Net Assets, Total Assets & Total Liabilities (2019–2024)

Cash in Bank

£114.64k

Decreased by £12.77k (-10%)

Net Assets

£371.83k

Decreased by £97.00 (-0%)

Total Liabilities

£27.43k

Decreased by £12.67k (-32%)

Turnover

N/A

Decreased by £10.85k (-100%)

Employees

N/A

Debt Ratio

N/A

Decreased by 10 (-100%)

Financial History

Revenue, profit, EBITDA and key financial figures

	2024 Dec Year End	2023 Dec Year End
P&L
Revenue	£142.3M	£128.7M
Gross Profit	£48.2M	£43.1M
Operating Profit	£22.4M	£19.8M
Net Profit	£18.1M	£15.9M
EBITDA	£31.5M	£28.2M
Assets
Cash	£24.7M	£21.3M
Total Assets	£89.4M	£82.1M
Liabilities
Total Liabilities	£45.2M	£41.8M
Key Metrics
Employees	1,247	1,156

Latest Revenue

£142.3M

Latest EBITDA

£31.5M

Cash Position

£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

2 active

Show resigned officers

						Status
Hannah Louise Selin	Director	British	England	44	3 Apr 2019	Active
Hannah Louise Selin	Secretary	Unknown	Unknown	—	7 May 2025	Active

Shareholders

Shareholders (1)


Autifony Therapeutics Limited	100.0%	68,119	Ordinary	6 May 2021

Persons with Significant Control

Persons with Significant Control (1)

1 Active

Autifony Therapeutics Limited

United Kingdom

Active

Notified 3 Apr 2019

Nature of Control

Ownership Of Shares 75 To 100 Percent
Voting Rights 75 To 100 Percent
Right To Appoint And Remove Directors

See All Controllers

Group Structure

AUTIFONY THERAPEUTICS LIMITED united kingdom shares 25 to 50 percent, voting rights 25 to 50 percent

TOUCHSTONE INNOVATIONS BUSINESSES LLP united kingdom right to share surplus assets 75 to 100 percent limited liability partnership

IP2IPO INNOVATIONS LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors

TOUCHSTONE INNOVATIONS LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors

IP GROUP PLC united kingdom

AUTIFONY ALPHA LIMITED Current Company

Charges

No charges registered

Documents

Company Filings

Date	Category	Description	Document
16 Jun 2025	Accounts	Annual accounts made up to 2024-09-30	View(12 pages)
7 May 2025	Officers	Appointment of Mrs Hannah Louise Selin as director on 2025-05-07	View(2 pages)
4 Apr 2025	Confirmation Statement	Confirmation statement made on 2025-04-02 with no updates	View(3 pages)
27 Jun 2024	Accounts	Annual accounts made up to 2023-09-30	View(11 pages)
4 Apr 2024	Confirmation Statement	Confirmation statement made on 2024-04-02 with no updates	View(3 pages)